Expression of mRNA coding for TGF-β and its receptors in irradiated human breast carcinoma MCF-7 cells differing in their sensitivity to doxorubicin

Experimental Oncology

Volumn 27, Issue 2, 2005, Pages 156-158

  Chorna, Inna ^a,b   Fedorenko, Oleksandr ^a   Datsyuk, Leonid ^b   Stoika, Rostyslav ^a,b  

^a INSTITUTE OF CELL BIOLOGY   (Ukraine)

^b IVAN FRANKO NATIONAL UNIVERSITY OF LVIV   (Ukraine)

Author keywords

Doxorubicin resistance; Mcf 7 human breast carcinoma cells; Transforming growth factor ; Type I and II receptors; X radiation

Indexed keywords

DOXORUBICIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RADIOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; X IRRADIATION;

ACTIVIN RECEPTORS, TYPE I; ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; X-RAYS;

EID: 22644431614     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Barcellos-Hoff MH, Derynck R, Tsang ML, Weatherbee JA. Transforming growth factor- beta activation in irradiated murine mammary gland. J Clin Invest 1994; 93: 892-9.
2. Chorna I, Bilyy R, Datsyuk L, Stoika R. Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin: effect of ionizing radiation on apoptosis and TGF-β production. Exp Oncol 2004; 26: 111-7.
3. Dennler S, Goumans MJ, ten Dijke P. Transforming growth factor beta signal transduction. J Leukoc Biol 2002; 71: 731-40.
4. 1 activation in situ: quantitative and functional evidence following low dose irradiation. FASEB J 1997; 11: 991-1002.
5. 1 mediates cellular response to DNA damage in situ. Cancer Res 2002; 62: 5627-31.
6. Gupta V, Harkin DP, Kawakubo H, Maheswaran S. Transforming growth factor-beta superfamily: evaluation as breast cancer biomarkers and preventive agents. Curr Cancer Drug Targets 2004; 4: 165-82.
7. Kaklamani VG, Pasche B. Role of TGF-beta in cancer and the potential for therapy and prevention. Expert Rev Anticancer Ther 2004; 4: 649-61.
8. Miyazono K, Suzuki H, Imamura T. Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci 2003; 94: 230-4.
9. Narayan S, Thangasamy T, Balusu R. Transforming growth factor -beta receptor signaling in cancer. Front Biosci. 2005; 10: 1135-45.
10. Souchelnytskyi S. Transforming growth factor-beta signaling and its role in cancer. Exp Oncol 2002; 24: 3-12.
11. Stoika R, Yakymovych M, Souchelnytskyi S, Yakymovych I. Potential role of transforming growth factor b1 in drug resistance of tumor cells. Acta Biochem Pol 2003; 50: 497-508.
12. Wakefield LM, Roberts AB. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002; 12: 22-9.